GCM
SGYP

Gruss Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Gruss Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-500,000
Closed -$1.38M – 55
2016
Q1 		$1.38M Buy
+500,000
New +$1.81M 0.04% 45

Other funds holding SGYP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Gruss Capital Management's SGYP Position: Q2 2016 in Review

Gruss Capital Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2016, closing a stake of 500,000 shares — an estimated $1.38M sold.

Gruss Capital Management first reported a position in SGYP in Q1 2016 and held it in 1 quarter. The position peaked at $1.38M in Q1 2016. 134 funds tracked by Wall St. Rank hold SGYP as of Q2 2016.

  • Gruss Capital Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2016 after selling out during the quarter.
  • Gruss Capital Management sold 500,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2016, an estimated $1.38M.
  • Gruss Capital Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2016 and held it in 1 quarter.
  • Gruss Capital Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.38M in Q1 2016.
  • 134 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2016.

Based on Gruss Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.